Stoke Therapeutics Inc
Biotechnology
Healthcare
STOK
59.40 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
22.86
52 week high
23.88
high
23.40
52 week low
0.00
low
22.51
growth
64.58 %
previous Close
22.85
P/E ratio
market cap
627 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
-71.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top